CS logo
small CS logo
Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin

Stuttgart, Germany

About Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
No rows

Clinical Trials at Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin


During the past decade, Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
No rows

Rows per page:

0–0 of 0

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin


According to Clinical.Site data, the most researched conditions in "Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin" are "Diffuse Large B-cell Lymphoma" (1 trials) and "Solid Tumours" (1 trials). Many other conditions were trialed in "Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin" in a lesser frequency.

Clinical Trials Intervention Types at Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin


Most popular intervention types in "Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin" are "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Gemcitabine" (1 trials), "Glofitamab" (1 trials), "Obinutuzumab" (1 trials), "Oxaliplatin" (1 trials) and "Rituxumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin


The vast majority of trials in "Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin" are 2 trials for "All" genders.

Clinical Trials Status at Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin


Currently, there are NaN active trials in "Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status